Nitrous Oxide
Regulatory activity · MHRAAlso known as Dinitrogen monoxide, Dinitrogen oxide, Laughing gas, N2O+4 more
Dinitrogen monoxide, Dinitrogen oxide, Laughing gas, N2O, N2O - nitrous oxide, óxido nitroso, Nitrious oxide, Nitrous oxide gas.
Recent clinical, regulatory, research and industry developments relating to this drug.
Functional MRI of Nitrous Oxide Inhalation in Volunteer Subjects
NMDA Receptor Antagonist Nitrous Oxide Targets Affective Brain Circuits
Self-Adjusted Nitrous Oxide: A Feasibility Study in the Setting of Vasectomy
Anxiolysis for Laceration Repair in Children: A Multicenter Adaptive Randomized Trial
Adjunctive Nitrous Oxide for Acute Suicidal Ideation in Unipolar Depressed Hospitalized Patients
Treatment of Suicidal Ideation in the Emergency Department Using Nitrous Oxide - PROTORISC Pilote
Drug Safety Update: Nitrous oxide: neurological and haematological toxic effects
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Regulatory timeline
The complete regulatory record, grouped by authority — approvals, safety advisories and label changes. Each authority shows its most recent events; expand one to read its full history.
Contains public sector information from the Medicines and Healthcare products Regulatory Agency (MHRA) licensed under the Open Government Licence (OGL v3).
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Journals, researchers & institutions
- The Journal of neuroscience : the official journal of the Society for Neuroscience1
- Benshoff ND1
- Dikranian K1
- Hartman RE1
- Izumi Y1
- Jevtovic-Todorovic V1
- Olney JW1
- Wozniak DF1
- Zorumski CF1
- University of Virginia Health System1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 4 of the same disease areas as Nitrous Oxide in the shared literature.
Studied across 4 of the same disease areas as Nitrous Oxide in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials
- Regulatory event sources are credited in the Regulatory Timeline above.